Institut Lavoisier (CNRS 8180) Institut universitaire de France, Université de Versailles, 78035 Versailles Cedex, France.
Nat Mater. 2010 Feb;9(2):172-8. doi: 10.1038/nmat2608. Epub 2009 Dec 13.
In the domain of health, one important challenge is the efficient delivery of drugs in the body using non-toxic nanocarriers. Most of the existing carrier materials show poor drug loading (usually less than 5 wt% of the transported drug versus the carrier material) and/or rapid release of the proportion of the drug that is simply adsorbed (or anchored) at the external surface of the nanocarrier. In this context, porous hybrid solids, with the ability to tune their structures and porosities for better drug interactions and high loadings, are well suited to serve as nanocarriers for delivery and imaging applications. Here we show that specific non-toxic porous iron(III)-based metal-organic frameworks with engineered cores and surfaces, as well as imaging properties, function as superior nanocarriers for efficient controlled delivery of challenging antitumoural and retroviral drugs (that is, busulfan, azidothymidine triphosphate, doxorubicin or cidofovir) against cancer and AIDS. In addition to their high loadings, they also potentially associate therapeutics and diagnostics, thus opening the way for theranostics, or personalized patient treatments.
在健康领域,一个重要的挑战是使用无毒的纳米载体在体内有效输送药物。大多数现有的载体材料显示出较差的药物负载能力(通常低于运输药物的 5wt%,而载体材料)和/或简单吸附(或锚定)在纳米载体外表面的药物比例的快速释放。在这种情况下,具有能够调整其结构和孔隙率以实现更好的药物相互作用和高负载能力的多孔混合固体非常适合用作用于递送和成像应用的纳米载体。在这里,我们表明,具有工程化核心和表面以及成像特性的特定无毒铁(III)基多孔金属有机骨架作为高效控释挑战性抗肿瘤和逆转录病毒药物(即白消安、叠氮胸苷三磷酸、阿霉素或更昔洛韦)的优越纳米载体针对癌症和艾滋病。除了高负载量外,它们还可能与治疗和诊断相结合,从而为治疗学或个性化患者治疗开辟了道路。